Tim Hubbard and Niklas Blomberg to Keynote Clinical Genomics & Informatics Europe Conference & Expo

NEEDHAM, Mass. - July 9, 2013 - PRLog -- Bio-IT World and Cambridge Healthtech Institute are proud to announce two distinguished keynote presenters at the Fifth International Clinical Genomics & Informatics Europe Conference, to be held in Lisbon, Portugal from 4-6 December 2013.  The meeting will bring together the international genomics and informatics communities to evaluate opportunities for advancing next-generation sequencing and molecular diagnosis of complex diseases. With four dedicated tracks, the program will tackle the huge amounts of sequencing data produced by new technologies that present significant challenges for bioinformatics, both in terms of the analysis and interpretation of clinical data. Preliminary agenda details have been released and are available at http://www.clinicalgenomicsinformatics.com.

“Significant advancements in genomics and bioinformatics provide immense opportunities for clinical management of patients and precise diagnosis of disease. With that comes the mounting need for collaboration across the industry.  Clinical Genomics & Informatics Europe will provide the venue for international teams to come together and navigate these new opportunities and challenges for day-to-day application,” states Christina Lingham, Conference Executive Director at Cambridge Healthtech Institute.  

Keynote presenters include Dr. Tim Hubbard, Senior Group Leader of Wellcome Trust Sanger Institute and Dr. Niklas Blomberg, Founding Director of ELIXIR.  Additional featured speakers include Brian Haas, Manager of Genome Annotation at the Broad Institute of MIT and Harvard; Marcel Dinger, Head of Clinical Genomics at the Garvan Institute of Medical Research; and David Barton, Chair of the European Molecular Genetics Quality Network.  The presenters will deliver real-world insights for advancing biomedical research through four dedicated fields: Clinical Exome Sequencing, RNA Sequencing and Transcriptome Analysis, High-Scale Computing, and Genome Informatics.  Also available at the event are two technical symposia on Clinical Epigenetics and Quantitative Digital Detection Technologies.

For more information on Clinical Genomics & Informatics Europe, visit the event website at http://www.clinicalgenomicsinformatics.com.

About Bio-IT World

Bio-IT World (www.bio-itworld.com) is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery, development and clinical trials.  Bio-IT World's focus explores themes at the intersection of IT and biomedical research, including big data, next-generation technologies, innovative informatics, and software tools, pushing towards a new era of precision medicine. The group also produces a variety of e-newsletters, web alerts, web symposia, podcasts, topic-specific briefings, white papers, and the Bio-IT World Best Practices Awards. In addition to the flagship Bio-IT World Expo in Boston, the group also organizes conferences in Europe and Asia, an annual West Coast Symposium, and co-produces The Clinical Genome Conference. Established in 2001, Bio-IT World has been published by Cambridge Healthtech Institute since 2006. It is based in Needham, Mass.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI) (www.chicorporate.com), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations.  Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.